Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat

Free Radical Biology and Medicine

Volumn 26, Issue 7-8, 1999, Pages 785-800

  Dalloz, Florence ^a   Maingon, Philippe ^b   Cottin, Yves ^b   Briot, François ^c   Horiot, Jean Claude ^b   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c CENTRE DE VALDUC   (France)

Author keywords

Antioxidant; Doxorubicin; Electron spin resonance; Free radicals; Irradiation; Ischemia; Isolated perfused rat heart; Reperfusion

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; DOXORUBICIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; GAMMA IRRADIATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; LIPID PEROXIDATION; MALE; MYOCARDIAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; CATALASE; COBALT RADIOISOTOPES; DEHYDROASCORBIC ACID; DOXORUBICIN; GAMMA RAYS; GLUTATHIONE PEROXIDASE; HEART; HEART RATE; HEMODYNAMIC PROCESSES; KINETICS; LIPID PEROXIDATION; MALE; MYOCARDIUM; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TIME FACTORS; VITAMIN E;

ANIMALIA;

EID: 0032921554     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00259-7     Document Type: Article

References (56)

1. Stewart J.R., Fajardo L.F. Dose response in human and experimental radiation- induced heart disease. Radiology. 99:1971;403-408.
2. Fajardo L.F., Stewart J.R. Experimental radiation-induced heart disease. I: Light microscopic studies. Am. J. Pathol. 59:1970;299-316.
3. Maeda S. Pathology of experimental radiation pancarditis. I. Observation on radiation- induced heart injuries following a single dose of X-ray irradiation to rabbit heart with special reference to its pathogenesis. Acta Pathol. Jpn. 30:1980;59-78.
4. Kahn M.Y. Radiation induced cardiomyopathy. 1. An electron microscopic study of cardiac muscle cells. Am. J. Pathol. 73:1973;131-146.
5. Benoff L.J., Schweitzer P. Radiation-induced heart disease - Reply. Am. Heart J. 131:1996;1237-1238.
6. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity analysis of prevailing hypotheses . FASEB J. 4:1990;3076-3086.
7. Keiser H.G., Pinedo H.M., Schuurhuis G.J., Joenje H. Doxorubicin (adriamycin) a critical review of free radical-dependent mechanisms of cytotoxicity . Pharmacol. Ther. 47:1990;219-231.
8. Danesi R., Del Tacca M., Della Torre P., Bernardini C. General and cardiac toxicity of adriamycinol in rats. Anticancer Res. 6:1986;967-972.
9. Monti E., Piccinini F., Villani F., Favalli L. Myocardial contractility and heart pharmacokinetics od adriamycin following a single administration in rat. Cancer Chemother. Pharmacol. 18:1986;289-291.
10. Cottin Y., Ribuot C., Maupoil V., Godin D., Arnould L., Brunotte F., Rochette L. Early incidence of adriamycin treatment on cardiac parameters in the rat. Can. J. Physiol. Pharmacol. 72:1994;140-145.
11. Mushlin P.S., Olson R.D. Anthracycline cardiotoxicity new insights . Rational Drug Ther. 22:1988;1-8.
12. Benderitter M., Maingon P., Abadie C., Assem M., Maupoil V., Briot F., Horiot J.C., Rochette L. Effect of in vivo heart irradiation on the development of antioxidant defenses and cardiac functions in the rat. Radiat. Res. 144:1995;64-72.
13. Langendorff O. Untersuchungen am überlebenden saügertierherzen. Pflügers Arch. Physiol. 61:1895;291-332.
14. Buettner G.R., Jurkiewicz B.A. Ascorbate free radical as a marker of oxidative stress an EPR study . Free Radic. Biol. Med. 14:1993;49-55.
15. Vergely C., Maupoil V., Benderitter M., Rochette L. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and post-ischemic recovery during reperfusion. Free Radic. Biol. Med. 24:1998;470-479.
16. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
17. Roe J.H., Kuether C.A. The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivatives of dehydroascorbic acid. J. Biol. Chem. 147:1943;399-407.
18. Burton G.W., Webb A., Ingold K.U. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids. 20:1985;29-39.
19. Aebi H. Catalase in vitro. Methods Enzymol. 105:1984;121-126.
20. Clairbone A. Catalase activity. Dreenwald R.A. Handbook of methods for oxygen radical research. 1985;283-284 CRC Press, Boca Raton.
21. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958.
22. McCord J.M., Fridowich J. Superoxide dismutase, an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
23. Flohe L., Otting W.A. Assay of glutathione peroxidase. Methods Enzymol. 105:1985;114-120.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-276.
25. Cappelli V., Moggio R., Monti E., Paracchini L., Piccinini F., Reggiani C. Reduction of myofibrillar ATPase activity and isomyosin shift in delayed doxorubicin cardiotoxicity. J. Mol. Cell. Cardiol. 21:1989;93-101.
26. Tong J., Ganguly P.K., Singal P.K. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am. J. Physiol. 260:1991;H909-H916.
27. Kawasaki N., Jee J.-D., Shimizu H., Ishii Y., Ueda T. Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats. Int. J. Cardiol. 55:1996;217-225.
28. Robison T.W., Giri S.N. Effects of chronic administration of doxorubicin on myocardial beta-adrenergic receptors. Life Sci. 39:1986;731-736.
29. Thayer W.S. Serum lipid peroxides in rats treated chronically with adriamycin. Biochem. Pharmacol. 33:1984;2259-2263.
30. Keller A.M., Jackson J.A., Peshock R.M., Rehr R.B., Willerson J.T., Nunnally R.L., Buja L.M. Nuclear magnetic resonance study of high-energy phosphate stores in models of adriamycin cardiotoxicity. Magn. Reson. Med. 3:1986;834-843.
31. Kapelko V.I., Williams C.P., Gutstein D.E., Morgan J.P. Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathy. Arch. Physiol. Biochem. 104:1996;185-191.
32. Lanza E., Rozza A., Favalli L., Monti E., Poggi P., Villani F. The rat model in the comparative evaluation of anthracyclines cardiotoxicity. Tumori. 75:1989;533-536.
33. Hirano S., Wakazono K., Agata N., Iguchi H., Tone H. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat. Drugs Exp. Clin. Res. 20:1994;153-160.
34. Sorini C., Vailati G., Colombo R., Paracchini L., Monti E. Morphological aspects of the delayed cardiotoxicity induced by doxorubicin in the rat. J. Exp. Clin. Cancer Res. 8:1989;47-53.
35. Iliskovic N., Singal P.K. Lipid lowering an important factor in preventing adriamycin-induced heart failure . Am. J. Pathol. 150:1997;727-734.
36. Yeung T.K., Simmonds R.H., Hopewell J.W. A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the rat. Radiother. Oncol. 15:1989;275-284.
37. Kapelko V.I., Popovich M.I., Sharov V.G., Kostin S.I., Shulzhenko V.S., Golikov M.A., Saks V.A. Ultrastructural, metabolic and functional alterations of the heart at prolonged adriamycin treatment. J. Appl. Cardiol. 4:1989;79-87.
38. Bianchi C., Bagnato A., Paggi M.G., Floridi A. Effect of adriamycin on electron transport in rat heart, liver, and tumor mitochondria. Exp. Mol. Pathol. 46:1987;123-135.
39. Dekker T., Van Echteld C.J.A., Kirkels J.H., Ruigrok T.J.C. Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR. NMR Biomed. 4:1991;16-24.
40. 2+ sensitivity of contractile proteins. Environ. Toxic. Pharmacol. 1:1996;131-139.
41. Rajagopalan S., Politi P.M., Sinha B.K., Myers C.E. Adriamycin-induced free radical formation in the perfused rat heart implications for cardiotoxicity . Cancer Res. 48:1988;4766-4769.
42. Ogura R., Sugiyama M., Haramaki N., Hidaka T. Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial damages. Cancer Res. 51:1991;3555-3558.
43. Singal P.K., Tong J. Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes. Mol. Cell. Biochem. 84:1988;163-171.
44. Tanaka Y., Takahashi K. Cardiac oxygen radical metabolism in adriamycin-induced cardiotoxicity. Jikeikai Med. J. 37:1990;253-264.
45. Luo X., Evrovsky Y., Cole D., Trines J., Benson L.N., Lehotay D.C. Doxorubicin-induced changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat. Biochim. Biophys. Acta. 1360:1997;45-52.
46. Przybyszewski W.M., Widel M., Koterbicka A. Early peroxidising effects of myocardial damage in rats after gamma-irradiation and farmorubucin (4-epiDXR) treatment. Cancer Lett. 81:1994;185-192.
47. Erhola M., Kellokumpu-Lehtinen P., Metsä-Ketela T., Alanko K., Nieminen M.M. Effects of anthracycline-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radic. Biol. Med. 21:1996;383-390.
48. Fujita K., Shinpo K., Yamada K., Sato T., Niimi H., Shamoto M., Nagatsu T., Takeuchi T., Umezawa H. Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs. Cancer Res. 42:1982;309-316.
49. Zipper J. Proliferation of myocardial peroxisomes caused by several agents and conditions. J. Mol. Cell. Cardiol. 29:1997;149-161.
50. Porta E.A., Joun N.S., Matsumura L., Nakasone B., Sablan H. Acute adriamycin cardiotoxicity in rats. Res. Commun. Chem. Pathol. Pharmacol. 41:1983;125-137.
51. Doroshow J.H., Locker G.Y., Myers C.E. Enzymatic defenses of the mouse heart against reactive oxygen metabolites. Alterations produced by doxorubicin. J. Clin. Invest. 65:1980;128-135.
52. Yen H.-C., Oberley T.D., Vichitbandha S., Ho Y.-S., St. Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced cardiac toxicity in transgenic mice. J. Clin. Invest. 98:1996;1253-1260.
53. Julicher R.H.M., Sterrenberg L., Haenen G.R.M., Bast A., Noordhoek J. The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat. Arch. Toxicol. 61:1988;275-281.
54. Nowak D., Drzewoski J. Anthracycline-induced oxidative stress - its role in the development of cardiac damage. Cancer J. 9:1996;296-303.
55. Gille L., Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic. Biol. Med. 23:1997;775-782.
56. Kayden H.J., Traber M.G. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34:1993;343-358.